International Patent: HYDROLYZABLE LINKER COMPOUNDS FOR ANTIBODY-DRUG CONJUGATES AND USES THEREOF

GENEVA, Aug. 31 -- BRISTOL-MYERS SQUIBB COMPANY filed a patent application (US2026/015437) for “HYDROLYZABLE LINKER COMPOUNDS FOR ANTIBODY-DRUG CONJUGATES AND USES THEREOF”. With publication no. WO/2026/178001, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 47/50

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....